Cronos Group Inc vs Mongodb Inc — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while Mongodb Inc trades at $385.93 (market cap $29.24B). The key difference: Mongodb Inc is far larger — about 24.8× Cronos Group Inc's market cap, and Cronos Group Inc is more actively traded (968,037 versus 1,304,995). Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Mongodb Inc for 46 Days on average.
| CRON | MDB | |
|---|---|---|
Market Cap | $1.18B | $29.24B |
Volume | 968,037 | 1,304,995 |
Sector | Health | Technology |
52-Week High | $3.55 | $472.29 |
52-Week Low | $2.30 | $225.95 |
Typical Hold Time | 22 Days | 46 Days |
Enterprise Value | $387.62M | $26.86B |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.23, down 0.31% with a bearish technical signal. Recent earnings show volatility with Q2 2026 beating expectations ($0.09 vs $0.01) but Q4 2025 missing. Revenue grew from $118M (2024) to $147M (2025), though net income turned negative at -$9M. The company maintains strong liquidity with $827M cash and no debt, highlighted in recent investor day presentations.
Outlook is mixed: analyst consensus leans Hold (60%) with cautious optimism on international expansion and margin improvements. Key risks include sustained negative cash flow (-$67M in 2025) and competitive pressures. Upside hinges on execution of growth initiatives in Canada and Europe, with profitability projections for 2026.
MongoDB (MDB) trades at $371.35, up 2.29% today, showing strong momentum after recent volatility. The stock maintains bullish technical signals with support at $366 and resistance at $375. Fundamentally, revenue growth remains robust at $2.01B for 2025, though the company continues to report net losses. Recent investor day highlighted AI product launches and raised long-term targets, offsetting concerns about CEO transition. Analyst consensus remains strongly bullish with 80% buy ratings and $456.76 price target, representing 23% upside potential.
MDB presents a growth investment opportunity with significant AI-driven upside potential, though elevated valuation metrics (P/E 511) and ongoing profitability challenges warrant caution. The company's strategic focus on AI infrastructure and enterprise partnerships supports long-term growth narrative, but execution risks during leadership transition and competitive pressures in database markets require monitoring. Current technical setup favors near-term strength with proper risk management.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
Read more on MDB →